Fundraise / allotmentNotableFiled on BSE ·

Krishna Institute of Medical Sciences receives NSE and BSE in-principle approval for warrant issue

Krishna Institute of Medical Sciences · Healthcare Services

Arthneeti Research DeskPublished 1 min read

Key highlights

  • In-principle approval granted on August 7, 2026, for issuing 77,02,182 warrants convertible into equity shares of Rs. 2 each
  • Warrants to be allotted to promoters/promoter group: Dr. Abhinay Bollineni, Mr. Adwik Bollineni, and Bharas Ventures LLP on a preferential basis
  • Company must comply with SEBI (LODR) Regulations, obtain necessary statutory approvals, and ensure internal controls for allottee trades before listing

Why it's rated notable: The filing gives no issue price or amount, and the in-principle approval is subject to conditions including statutory approvals, so the level stays at medium.

Original filing

Intimation Of Receipt Of The In-Principle Approval From BSE Limited And The National Stock Exchange Of India Limited

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Krishna Institute of Medical Sciences

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.